Danaher Co. (NYSE:DHR) Shares Sold by Hedeker Wealth LLC

Hedeker Wealth LLC decreased its position in shares of Danaher Co. (NYSE:DHR) by 0.4% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,332 shares of the conglomerate’s stock after selling 45 shares during the period. Hedeker Wealth LLC’s holdings in Danaher were worth $2,830,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of DHR. Naviter Wealth LLC increased its holdings in Danaher by 4.9% during the 1st quarter. Naviter Wealth LLC now owns 7,663 shares of the conglomerate’s stock worth $1,916,000 after purchasing an additional 358 shares during the period. West Oak Capital LLC increased its holdings in shares of Danaher by 0.9% in the 1st quarter. West Oak Capital LLC now owns 9,776 shares of the conglomerate’s stock valued at $2,441,000 after acquiring an additional 85 shares during the last quarter. Financial Security Advisor Inc. increased its holdings in shares of Danaher by 15.5% in the 1st quarter. Financial Security Advisor Inc. now owns 1,728 shares of the conglomerate’s stock valued at $432,000 after acquiring an additional 232 shares during the last quarter. Dash Acquisitions Inc. increased its holdings in shares of Danaher by 1.6% in the 1st quarter. Dash Acquisitions Inc. now owns 62,778 shares of the conglomerate’s stock valued at $15,028,000 after acquiring an additional 960 shares during the last quarter. Finally, Capital Advisors Ltd. LLC increased its holdings in shares of Danaher by 2.4% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,888 shares of the conglomerate’s stock valued at $471,000 after acquiring an additional 44 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent analyst reports. Jefferies Financial Group initiated coverage on Danaher in a report on Monday, June 3rd. They issued a “buy” rating and a $295.00 price objective on the stock. Bank of America increased their price objective on Danaher from $258.00 to $270.00 and gave the company a “neutral” rating in a report on Wednesday, April 24th. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and raised their price target for the stock from $250.00 to $280.00 in a research note on Wednesday, April 17th. Robert W. Baird raised their price target on Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 24th. Finally, Citigroup raised their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research note on Wednesday, April 24th. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $268.67.

Insider Activity

In other news, Director Alan G. Spoon sold 708 shares of Danaher stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the completion of the sale, the director now owns 116,202 shares of the company’s stock, valued at $28,304,483.16. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CEO Rainer Blair sold 9,005 shares of Danaher stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $265.00, for a total value of $2,386,325.00. Following the transaction, the chief executive officer now owns 106,990 shares in the company, valued at $28,352,350. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Alan G. Spoon sold 708 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $243.58, for a total value of $172,454.64. Following the transaction, the director now owns 116,202 shares in the company, valued at approximately $28,304,483.16. The disclosure for this sale can be found here. Insiders sold a total of 148,783 shares of company stock valued at $37,536,717 over the last quarter. Company insiders own 10.90% of the company’s stock.

Danaher Price Performance

Danaher stock traded up $1.64 during mid-day trading on Wednesday, hitting $242.05. 280,372 shares of the company were exchanged, compared to its average volume of 2,855,673. The company has a market capitalization of $179.28 billion, a P/E ratio of 40.75, a PEG ratio of 3.82 and a beta of 0.84. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. Danaher Co. has a 12-month low of $182.09 and a 12-month high of $269.11. The business’s 50 day simple moving average is $256.13 and its two-hundred day simple moving average is $246.86.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The business’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.36 earnings per share. Analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend is Friday, June 28th. Danaher’s dividend payout ratio is currently 18.31%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.